Sept 5 (Reuters) - Drug distributor McKesson on
Thursday forecast second-quarter profit below Wall Street
estimates.
The company expects adjusted profit for the second quarter
to be between $6.70 and $7 per share, compared with analysts'
average estimate of $7.39, according to LSEG data.